Highlights of drug package inserts and the website dailymed: The need for further improvement in package inserts to help busy prescribers

Journal of Clinical Psychopharmacology

Volumn 31, Issue 3, 2011, Pages 263-265

  De Leon, Jose ^a,b  

^a Eastern State Hospital   (United States)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; ASENAPINE; CAFFEINE; CIPROFLOXACIN; CYTOCHROME P450 3A4; FLUOXETINE; FLUVOXAMINE; GENERIC DRUG; PAROXETINE; PHENOBARBITAL; PHENYTOIN; RIFAMPICIN; TERFENADINE; THEOPHYLLINE;

APPENDICITIS; ASTHMA; CHRONIC BRONCHITIS; CYTOKINE RELEASE; DRUG DOSE REGIMEN; DRUG INDUSTRY; DRUG INFORMATION; DRUG INTERACTION; DRUG MARKETING; DRUG METABOLISM; DRUG RECALL; DRUG TOXICITY; EDITORIAL; FEVER; FOOD AND DRUG ADMINISTRATION; INTERNET; LETHALITY; NURSE PRACTITIONER; PHYSICIAN; PHYSICIAN ASSISTANT; PRESCRIPTION; PRIORITY JOURNAL; SMOKING; UPPER RESPIRATORY TRACT INFECTION;

DRUG INDUSTRY; DRUG LABELING; HEALTH PERSONNEL; HUMANS; INTERNET;

EID: 79955636562     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318218f3e4     Document Type: Editorial

References (15)

1. Mitka M. Drug package inserts get mixed reception. JAMA. 2006;295:1110-1111. (Pubitemid 43352329)
2. Issa AM, Phillips KA, Van Bebber S, et al. Drug withdrawals in the United States: a systematic review of the evidence and analysis of trends. Curr Drug Saf. 2007;2:177-185. (Pubitemid 47578123)
3. de Leon J, Spina E, Diaz FJ. Pharmacokinetic drug interaction studies must consider pharmacological heterogeneity, use of repeated dosing and translation into a message understandable to practicing clinicians. J Clin Psychopharmacol. 2009;29:201-205.
4. FDA's new prescribing information. Available at: http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/ LawsActsandRules/ ucm085261.pdf. Accessed January 16, 2011.
5. Abilify highlights. Available at: http://dailymed.nlm.nih.gov/ dailymed/search.cfm?startswith=aripiprazole&x=14&y=4. Accessed January 16, 2011.
6. de Leon J, Armstrong SC, Cozza KL. The dosing of atypical antipsychotics. Psychosomatics. 2005;46:262-273. (Pubitemid 40594318)
7. Spina E, de Leon J. Metabolic drug interactions with newer antipsychotics: a comparative review. Basic Clin Pharmacol Toxicol. 2007;100:4-22. (Pubitemid 46051438)
8. Saphris highlights. Available at: http://dailymed.nlm.nih.gov/ dailymed/search.cfm?startswith=asenapine&x=7&y=10. Accessed January 16, 2011.
9. Flockhart DA. Drug interactions, cardiac toxicity, and terfenadine: from bench to clinic? J Clin Psychopharmacol. 1996;16:101-103. (Pubitemid 26141748)
10. Clozapine. Available at: http://dailymed.nlm.nih.gov/dailymed/ search.cfm?startswith=clozapine. Accessed January 16, 2011.
11. Diaz FJ, Santero V, Spina E, et al. Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables. Pharmacopsychiatry. 2008;41:81-91. (Pubitemid 351796981)
12. Shilalukey K, Robieux I, Spino M, et al. Are current pediatric dose recommendations for intravenous theophylline appropriate? J Asthma. 1993;30:109-121. (Pubitemid 23107347)
13. Theophylline. Available at: http://dailymed.nlm.nih.gov/dailymed/ search.cfm?startswith=THEOPHYLLINE&x=13&y=15. Accessed January 16, 2011.
14. de Leon J, Diaz FJ. Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:1059-1063. (Pubitemid 37141394)
15. de Leon J. Respiratory infections rather than antibiotics may increase clozapine levels: a critical review of the literature (letter). J Clin Psychiatry. 2006;65:1144-1145.